Immunotherapy and cell therapy have revolutionized the field of cancer treatment by harnessing the power of the immune system to fight cancer cells. However, the development of effective immunotherapy drugs such as immune checkpoint inhibitors requires extensive preclinical testing to ensure safety and efficacy. Breakthroughs in the field are faced with several challenges including the generation of appropriate humanized mouse models for preclinical evaluation. Among others, genetically-engineered mouse models have emerged as valuable tools for improving cancer treatment outcomes.
July 13, 2023
- A Brief History of Flow Cytometry
- Silent but Deadly, and Beneficial? – Natural Killer Cells
- The Basophil Activation Test: An Application of Flow Cytometry for Allergy Testing in Clinical Trials
- Navigating the Preclinical-to-Clinical Transition for ADCs: Regulatory & Study Design Strategies
- Featured Guest Blog: Quality is Critical by Mary E. Lynn
A Brief History of Flow Cytometry
By Darcey L. Clark, MS DABT, Senior Biotechnology Professional
Silent but Deadly, and Beneficial? – Natural Killer Cells
By Jayne Schaubhut, Lab Supervisor Natural Killer (NK) cells play a major role in targeting and killing both tumor cells and virally infected cells ...
The Basophil Activation Test: An Application of Flow Cytometry for Allergy Testing in Clinical Trials
By Sarah Johnson, Research Associate
Get Started
Contact Us Today!
If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.
